Stocks To Watch…. Companies whose shares are expected to trade actively in today’s session are CapLease, Inc. (NYSE:LSE) (NYSE:LSE-A) (NYSE:LSE-B), Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB), pSivida Corp. (NASDAQ:PSDV), Greenbrier Companies Inc (NYSE:GBX), Mitcham Industries, Inc. (NASDAQ:MIND) and Compuware Corporation (NASDAQ:CPWR).
CapLease, Inc. (NYSE:LSE) (NYSE:LSE-A) (NYSE:LSE-B): The real estate investment trust announced plans to offer 6.5 million shares in a public offering. As of February 15, the company had 76 million outstanding shares. Prices slipped 1.95 percent to $6.03 in the early session.
Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB): The biotherapeutics company announced that its cancer drug Lymphoseek has achieved the primary objective of identifying the sentinel lymph nodes in the third phase of clinical trials. Shares soared 8.63 percent to $2.77 in the early session.
pSivida Corp. (NASDAQ:PSDV): The pharmaceutical company has signed a technology evaluation agreement with a large pharmaceutical company. The agreement will evaluate its Durasert™ and Tethadur™ technologies for the unnamed pharmaceutical company’s products in ophthalmology. Durasert™ delivers a predetermined quantity of drugs to the target site on the patient’s body for a predetermined period ranging from a few weeks to months. Shares soared 11.06 percent to $2.51 in the early session.
Greenbrier Companies Inc (NYSE:GBX): The railroad freight car equipment maker announced a 22 percent decline in its second quarter earnings. The company said the new product deliveries continue to slide. Shares fell 3.72 percent to $20.99 in early market trading.
Mitcham Industries, Inc. (NASDAQ:MIND): The seismic equipment supplier’s fourth quarter profits declined 66 percent compared to the previous year as revenues from equipment leasing continued to decline. Earnings missed Wall Street’s estimates. Shares slumped 5.11 percent to $15.59 in the early session.
Compuware Corporation (NASDAQ:CPWR): The company said its fourth quarter and full year earnings would miss previous estimates. Compuware said several clients failed to finalize their budgets, so they pushed the deals into the new year. Shares slipped 0.91 percent to $11.91 in the early session.